These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 12860472)

  • 21. Inhibition by ethanol of rat P2X(4) receptors expressed in Xenopus oocytes.
    Xiong K; Li C; Weight FF
    Br J Pharmacol; 2000 Jul; 130(6):1394-8. PubMed ID: 10903981
    [TBL] [Abstract][Full Text] [Related]  

  • 22. P2X currents in peritoneal macrophages of wild type and P2X4 -/- mice.
    Brône B; Moechars D; Marrannes R; Mercken M; Meert T
    Immunol Lett; 2007 Nov; 113(2):83-9. PubMed ID: 17825926
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Mg(2+) inhibits ATP-activated current mediated by rat P2X4 receptors expressed in Xenopus oocytes].
    Peng F; Zhang YQ; Zeng Y; Zhou YL
    Sheng Li Xue Bao; 2012 Feb; 64(1):75-81. PubMed ID: 22348964
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of the binding characteristics of recombinant P2X1 and P2X2 purinoceptors.
    Michel AD; Lundström K; Buell GN; Surprenant A; Valera S; Humphrey PP
    Br J Pharmacol; 1996 Aug; 118(7):1806-12. PubMed ID: 8842447
    [TBL] [Abstract][Full Text] [Related]  

  • 25. P2x-purinoceptors of myenteric neurones from the guinea-pig ileum and their unusual pharmacological properties.
    Barajas-López C; Huizinga JD; Collins SM; Gerzanich V; Espinosa-Luna R; Peres AL
    Br J Pharmacol; 1996 Dec; 119(8):1541-8. PubMed ID: 8982499
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular cloning and functional expression of Xenopus laevis oocyte ATP-activated P2X4 channels.
    Juranka PF; Haghighi AP; Gaertner T; Cooper E; Morris CE
    Biochim Biophys Acta; 2001 May; 1512(1):111-24. PubMed ID: 11334629
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation of ATP-responses at recombinant rP2X4 receptors by extracellular pH and zinc.
    Wildman SS; King BF; Burnstock G
    Br J Pharmacol; 1999 Feb; 126(3):762-8. PubMed ID: 10188989
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Full sensitivity of P2X2 purinoceptor to ATP revealed by changing extracellular pH.
    King BF; Ziganshina LE; Pintor J; Burnstock G
    Br J Pharmacol; 1996 Apr; 117(7):1371-3. PubMed ID: 8730726
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression level dependent changes in the properties of P2X2 receptors.
    Clyne JD; Brown TC; Hume RI
    Neuropharmacology; 2003 Mar; 44(3):403-12. PubMed ID: 12604087
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of neuroamines and divalent cations on cloned and mutated ATP-gated channels.
    Nakazawa K; Ohno Y
    Eur J Pharmacol; 1997 Apr; 325(1):101-8. PubMed ID: 9151945
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stoichiometry and conditional stability constants of Cu(II) or Zn(II) clioquinol complexes; implications for Alzheimer's and Huntington's disease therapy.
    Ferrada E; Arancibia V; Loeb B; Norambuena E; Olea-Azar C; Huidobro-Toro JP
    Neurotoxicology; 2007 May; 28(3):445-9. PubMed ID: 17382398
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selectivity of diadenosine polyphosphates for rat P2X receptor subunits.
    Wildman SS; Brown SG; King BF; Burnstock G
    Eur J Pharmacol; 1999 Feb; 367(1):119-23. PubMed ID: 10082274
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selective potentiation of homomeric P2X2 ionotropic ATP receptors by a fast non-genomic action of progesterone.
    De Roo M; Boué-Grabot E; Schlichter R
    Neuropharmacology; 2010 Mar; 58(3):569-77. PubMed ID: 20004677
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of extracellular histidines in antagonist sensitivity of the rat P2X4 receptor.
    Xiong K; Stewart RR; Weight FF; Li C
    Neurosci Lett; 2004 Sep; 367(2):197-200. PubMed ID: 15331152
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ionic selectivity of native ATP-activated (P2X) receptor channels in dissociated neurones from rat parasympathetic ganglia.
    Liu DM; Adams DJ
    J Physiol; 2001 Jul; 534(Pt. 2):423-35. PubMed ID: 11454961
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutation of histidine 286 of the human P2X4 purinoceptor removes extracellular pH sensitivity.
    Clarke CE; Benham CD; Bridges A; George AR; Meadows HJ
    J Physiol; 2000 Mar; 523 Pt 3(Pt 3):697-703. PubMed ID: 10718748
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Developmental changes in P2X purinoceptors on glycinergic presynaptic nerve terminals projecting to rat substantia gelatinosa neurones.
    Jang IS; Rhee JS; Kubota H; Akaike N; Akaike N
    J Physiol; 2001 Oct; 536(Pt 2):505-19. PubMed ID: 11600685
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lack of run-down of smooth muscle P2X receptor currents recorded with the amphotericin permeabilized patch technique, physiological and pharmacological characterization of the properties of mesenteric artery P2X receptor ion channels.
    Lewis CJ; Evans RJ
    Br J Pharmacol; 2000 Dec; 131(8):1659-66. PubMed ID: 11139444
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A P2X purinoceptor cDNA conferring a novel pharmacological profile.
    Bo X; Zhang Y; Nassar M; Burnstock G; Schoepfer R
    FEBS Lett; 1995 Nov; 375(1-2):129-33. PubMed ID: 7498461
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The binding characteristics of a human bladder recombinant P2X purinoceptor, labelled with [3H]-alpha beta meATP, [35S]-ATP gamma S or [33P]-ATP.
    Michel AD; Lundström K; Buell GN; Surprenant A; Valera S; Humphrey PP
    Br J Pharmacol; 1996 Mar; 117(6):1254-60. PubMed ID: 8882623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.